EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY-NC 4.0

Evaluating the Potential of Galactosaminogalactan as a Diagnostic Target for Invasive Aspergillosis

Takahiro Takazono iD, Kiyotaka Machida, Francois Le Mauff, Donald C Sheppard, Satoru Koga, Hotaka Namie, Haretsugu Hishigaki, Junichi Amata, Yuya Ito, Nana Nakada, Tatsuro Hirayama, Masataka Yoshida und 11 weitere

Mycoses · 2025

DOI: 10.1111/myc.70125 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Mycoses, 2025. Verfasst von Takahiro Takazono und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan. Hauptthemen laut MEDLINE: Invasive Pulmonary Aspergillosis, Polysaccharides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MSD Life Science Foundation, Public Interest Incorporated Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early diagnosis of invasive aspergillosis (IA) is critical for the initiation of effective antifungal therapy. Currently, detection of galactomannan (GM), a secreted fungal glycan, is the most used culture‐independent diagnostic test for IA. However, limitations in the sensitivity and specificity of this test have led to interest in identifying other target molecules. Galactosaminogalactan (GAG), a polysaccharide cell wall component secreted by Aspergillus hyphae, is a potential diagnostic marker for IA.

Objectives

To evaluate the utility of GAG as a diagnostic target, we generated a monoclonal antibody against GAG (mAb 1D1), established a GAG enzyme‐linked immunosorbent assay (ELISA), evaluated its cross‐reactivity with other respiratory pathogens, and compared the performance of the GAG detection ELISA with GM antigen detection in both an in vivo mouse model and human samples from patients with pulmonary aspergillosis.

Results

The GAG ELISA demonstrated strong reactivity with culture supernatants from Aspergillus fumigatus and Aspergillus flavus but limited reactivity with culture supernatants of other Aspergillus spp. and non‐ Aspergillus filamentous fungi. In a mouse model of IA, GAG was detected in lung tissue, serum, bronchoalveolar lavage fluid (BALF), and urine samples. Although GAG was detected by mAb 1D1 staining of Aspergillus hyphae in infected human lung tissue samples, it was not detectable in the serum, BALF, and urine of patients with pulmonary aspergillosis.

Conclusions

Further studies are required to determine whether the failure to detect GAG in the serum, BALF, and urine of patients with pulmonary aspergillosis is due to absence or low GAG levels or other reasons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Invasive Pulmonary AspergillosisPolysaccharidesAnimalsHumansMiceEnzyme-Linked Immunosorbent AssayAntibodies, MonoclonalDisease Models, AnimalSensitivity and SpecificityBronchoalveolar Lavage FluidAspergillusAspergillus fumigatusLungGalactoseAntigens, FungalMannansCross ReactionsFemaleMice, Inbred BALB CBiomarkers

Stichwörter der Autor:innen

Aspergillus fumigatusAspergillus flavuschronic pulmonary aspergillosisgalactomannangalactosaminogalactaninvasive aspergillosismonoclonal antibodymouse model

Substanzen

galactosaminogalactanAntibodies, MonoclonalgalactomannanPolysaccharidesGalactoseAntigens, FungalMannansBiomarkers

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Diagnostic Division, Otsuka Pharmaceutical Co. Ltd., Tokushima, Japan.
  • Infectious Disease and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
  • GlycoNet Integrated Services, Microbial Glycomic Node, Montreal, Quebec, Canada.
  • Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Takahiro Takazono, Naoki Iwanaga, Shotaro Ide

Förderung

  • MSD Life Science Foundation, Public Interest Incorporated Foundation

Zitieren

APA

Takazono, T., Machida, K., Le Mauff, F., Sheppard, D. C., Koga, S., Namie, H., Hishigaki, H., Amata, J., Ito, Y., Nakada, N., Hirayama, T., Yoshida, M., Takeda, K., Iwanaga, N., Ide, S., Tashiro, M., Hosogaya, N., Sakamoto, N., Matsumoto, K., …, & Mukae, H. (2025). Evaluating the Potential of Galactosaminogalactan as a Diagnostic Target for Invasive Aspergillosis. Mycoses. https://doi.org/10.1111/myc.70125

Vancouver

Takazono T, Machida K, Le Mauff F, Sheppard DC, Koga S, Namie H, et al. Evaluating the Potential of Galactosaminogalactan as a Diagnostic Target for Invasive Aspergillosis. Mycoses. 2025. doi:10.1111/myc.70125

BibTeX
@article{Takazono2025,
  author = {Takazono, Takahiro and Machida, Kiyotaka and Le Mauff, Francois and Sheppard, Donald C and Koga, Satoru and Namie, Hotaka and Hishigaki, Haretsugu and Amata, Junichi and Ito, Yuya and Nakada, Nana and Hirayama, Tatsuro and Yoshida, Masataka and Takeda, Kazuaki and Iwanaga, Naoki and Ide, Shotaro and Tashiro, Masato and Hosogaya, Naoki and Sakamoto, Noriho and Matsumoto, Keitaro and Yanagihara, Katsunori and Miyazaki, Yasushi and Izumikawa, Koichi and Mukae, Hiroshi},
  title = {Evaluating the Potential of Galactosaminogalactan as a Diagnostic Target for Invasive Aspergillosis},
  journal = {Mycoses},
  year = {2025},
  doi = {10.1111/myc.70125}
}
Kostenlos starten →